Validation of a composite real-world mortality variable among patients with hematologic malignancies treated in the United States
Validation of a Composite Real-World Mortality Variable Among Patients with Hematologic Malignancies Treated in the United States
Reality Check: Real-world evidence to support therapeutic development in hematologic malignancies
